Hemodynamic unloading leads to regression of pulmonary vascular disease in rats

被引:44
作者
O'Blenes, SB
Fischer, S
McIntyre, B
Keshavjee, S
Rabinovitch, M
机构
[1] Univ Toronto, Hosp Sick Children, Dept Pediat, Div Cardiovasc Res, Toronto, ON M5G 1X8, Canada
[2] Univ Toronto, Hosp Sick Children, Dept Lab Med & Pathobiol, Toronto, ON M5G 1X8, Canada
[3] Univ Toronto, Hosp Sick Children, Dept Med, Toronto, ON M5G 1X8, Canada
[4] Toronto Gen Hosp, Res Inst, Thorac Surg Res Lab, Toronto, ON, Canada
基金
英国医学研究理事会;
关键词
D O I
10.1067/mtc.2001.111657
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Treatment options for patients with advanced pulmonary vascular disease caused by a congenital heart defect are still mainly limited to heart-lung transplantation or lung transplantation with repair of the cardiac lesion. Because we have previously shown that the structural changes associated with pulmonary hypertension can be reversed by stress unloading in an organ culture model, we now investigate whether hemodynamic unloading will lead to regression of pulmonary vascular disease in the intact animal. Methods: Right middle and lower lobectomy and monocrotaline injection were performed in Lewis rats (n = 22) to cause pulmonary vascular disease from a combined hemodynamic and toxic injury. Twenty-eight days later the left lungs were examined (n = 10) or exposed to normal pulmonary artery pressure for an additional 14 (n = 5) or 28 (n = 7) days by transplantation into: healthy recipients. Pulmonary artery pressure, ventricular weight, and pulmonary artery morphology were evaluated in each group. Results: Pulmonary hypertension (50 vs 16 mm Hg; P < .001) and right ventricular hypertrophy (right ventricular/left ventricular weight 0.69 vs 0.32; P < .001) associated with pulmonary artery medial hypertrophy (28.2% vs 7.2% wall thickness; P < .001) and muscularization of small pulmonary arteries (92.3% vs 19.4%; P < .001) developed by day 28 (compared with untreated controls). However, transplantation into healthy recipients effectively unloaded the lungs (mean pulmonary artery pressure 17 and 24 mm Hg at 14 and 28 days after transplantation) and resulted in progressive normalization of medial hypertrophy (15.6% and 12.1% at 14 and 28 days) and muscularization (65.1% and 42.2% at 14 and 28 days) relative to nontransplanted controls (P < .005 in each case). Conclusions: Hemodynamic unloading of lungs with pulmonary vascular disease results in progressive normalization of pulmonary artery structure. These results are the first to provide a rationale for attempting to induce regression of pulmonary vascular disease by pressure unloading of the pulmonary circulation. Methods to mechanically unload the pulmonary circulation should be critically evaluated as a strategy for staged surgical repair of congenital heart defects despite presumed irreversible pulmonary hypertension.
引用
收藏
页码:279 / 289
页数:11
相关论文
共 24 条
[1]  
AEBA R, 1993, CIRCULATION, V88, P452
[2]  
Campbell AIM, 1999, CIRCULATION, V100, P476
[3]   Complete reversal of fatal pulmonary hypertension in rats by a serine elastase inhibitor [J].
Cowan, KN ;
Heilbut, A ;
Humpl, T ;
Lam, C ;
Ito, S ;
Rabinovitch, M .
NATURE MEDICINE, 2000, 6 (06) :698-702
[4]   Elastase and matrix metalloproteinase inhibitors induce regression, and tenascin-C antisense prevents progression, of vascular disease [J].
Cowan, KN ;
Jones, PL ;
Rabinovitch, M .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (01) :21-34
[5]   Regression of hypertrophied rat pulmonary arteries in organ culture is associated with suppression of proteolytic activity, inhibition of tenascin-C, and smooth muscle cell apoptosis [J].
Cowan, KN ;
Jones, PL ;
Rabinovitch, M .
CIRCULATION RESEARCH, 1999, 84 (10) :1223-1233
[6]   EXTRACORPOREAL MEMBRANE-OXYGENATION AND THE TREATMENT OF CRITICAL PULMONARY-HYPERTENSION IN CONGENITAL HEART-DISEASE [J].
DHILLON, R ;
PEARSON, GA ;
FIRMIN, RK ;
CHAN, KC ;
LEANAGE, R .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 1995, 9 (10) :553-556
[7]  
FREMES SE, 1990, J THORAC CARDIOV SUR, V100, P1
[8]  
HERGET J, 1972, ARCH INT PHARMACOD T, V198, P107
[9]   Tenascin-C is induced with progressive pulmonary vascular disease in rats and is functionally related to increased smooth muscle cell proliferation [J].
Jones, PL ;
Rabinovitch, M .
CIRCULATION RESEARCH, 1996, 79 (06) :1131-1142
[10]   Regulation of tenascin-C, a vascular smooth muscle cell survival factor that interacts with the alpha(v)beta(3) integrin to promote epidermal growth factor receptor phosphorylation and growth [J].
Jones, PL ;
Crack, J ;
Rabinovitch, M .
JOURNAL OF CELL BIOLOGY, 1997, 139 (01) :279-293